Mounjaro 12.5 mg KwikPen | Tirzepatide Product Information
Product Details
Product Name: Mounjaro 12.5 mg KwikPen
Active Ingredient: Tirzepatide
Strength: 12.5 mg per dose
Dosage Form: Solution for Injection
Brand Name: Mounjaro KwikPen
Pack Size: 1 multi-dose pre-filled pen
Route of Administration: Subcutaneous injection
Pen Type: Multi-dose pre-filled KwikPen
Doses per Pen: 4 doses
Total Volume: 2.4 mL
Dose Volume: 0.6 mL per dose, as indicated on the packaging
Dosing Frequency: Once weekly, as prescribed
Manufacturer: Eli Lilly
Prescription Status: Prescription medicine
About Mounjaro 12.5 mg KwikPen
Mounjaro 12.5 mg KwikPen contains tirzepatide, a dual GIP and GLP-1 receptor agonist used for approved indications, including improving blood sugar control in adults with type 2 diabetes. Depending on the country, tirzepatide may also be approved for weight management.
Tirzepatide works by activating GIP and GLP-1 receptors, helping regulate blood glucose, appetite and food intake.
The 12.5 mg strength may be prescribed as part of an individualized treatment plan following gradual dose escalation. Treatment and dose selection should be determined by a qualified healthcare professional.
Important Safety Information
Use Mounjaro only as prescribed by a qualified healthcare professional.
Administer the injection subcutaneously according to the official product instructions.
Common side effects include nausea, vomiting, diarrhoea, constipation, abdominal discomfort and reduced appetite.
Inform your doctor if you have a history of pancreatitis, gallbladder disease or severe gastrointestinal problems.
The risk of low blood sugar may increase when Mounjaro is used with insulin or sulfonylureas.
Discuss your medical history and other medicines with your healthcare professional before starting treatment.
Follow the official instructions for pen preparation, administration, storage and disposal.
Seek urgent medical attention for severe persistent abdominal pain or symptoms of a serious allergic reaction.
Frequently Asked Questions
1. What is Mounjaro 12.5 mg KwikPen used for?
Mounjaro contains tirzepatide and is used for approved indications, including blood sugar control in adults with type 2 diabetes. In some countries, it is also approved for weight management.
2. How many doses are included in one Mounjaro 12.5 mg KwikPen?
One multi-dose KwikPen is designed to deliver four doses of 12.5 mg each, according to the product packaging.
3. How often is Mounjaro 12.5 mg administered?
It is generally administered once weekly, as prescribed by a healthcare professional.
4. Can treatment start directly at 12.5 mg?
Treatment usually starts at a lower dose and increases gradually under medical supervision. Do not begin treatment at 12.5 mg unless specifically directed by your healthcare professional.
5. Does Mounjaro 12.5 mg KwikPen require a prescription?
Yes. Mounjaro is a prescription medicine and should be used under appropriate medical supervision.
Instant Support – Call / WhatsApp Now
For product information and pharmaceutical supply enquiries, contact our team.
Call: +91 8007161282
Call: +91 9970011496
WhatsApp: https://wa.me/918007161282
